Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec 7;7(12):e0336.
doi: 10.1097/HC9.0000000000000336. eCollection 2023 Dec 1.

Collaborating with AI in literature search-An important frontier

Masaru Enomoto  1 , Cheng-Hao Tseng  2 , Yao-Chun Hsu  2 , Le Thi Thanh Thuy  1 , Mindie H Nguyen  3   4
Affiliations
Comment

Collaborating with AI in literature search-An important frontier

Masaru Enomoto et al. Hepatol Commun. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Cheng-Hao Tseng is on the speakers’ bureau for Roche. Yao-Chun Hsu consults, advises, is on the speakers’ bureau, and received grants from Gilead. He is on the speakers’ bureau and received grants from AbbVie, Bristol-Myers Squibb, and Roche. He advises Sysmex and is on the speakers’ bureau for MSD. Mindie Nguyen consults and received grants from Gilead, GlaxoSmithKline, and Exact Science. She consults for Intercept and Exelixis. She received grants from Pfizer, Enanta, AstraZeneca, Delfi, Innogen, Curve Bio, Vir, Healio, NCI, and Glycotest. The remaining authors have no conflicts to report.

Comment on

References

    1. Ge J, Lai JC. Artificial intelligence-based text generators in hepatology: ChatGPT is just the beginning. Hepatol Commun. 2023;7:e0097. - PMC - PubMed
    1. Tseng CH, Hsu YC, Chen TH, Ji F, Chen IS, Tsai YN, et al. Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:1039–52. - PubMed
    1. https://elicit.org Elicit: The AI Research Assistant. Accessed: October 10, 2023.
    1. Ha I, Chung JW, Jang ES, Jeong SH, Kim JW. Comparison of the on-treatment risks for hepatocellular carcinoma between entecavir and tenofovir. J Gastroenterol Hepatol. 2020;35:1774–81. - PubMed
    1. Kim Y, Shin H, Lee J, Joo K, Cha J, Jeon J, et al. Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B. Saudi J Gastroenterol. 2018;24:326–35. - PMC - PubMed

MeSH terms